Insulin-like growth factor 1 (IGF-1) is one of the most potent anabolic hormones in the human body. It mediates many of growth hormone’s effects on muscle growth, tissue repair, and cellular proliferation. IGF-1 LR3 is a modified form of IGF-1 engineered for dramatically extended activity — making it one of the most potent growth factors available for research and therapeutic applications.
What Is IGF-1?
IGF-1 is a 70-amino-acid peptide hormone produced primarily by the liver in response to growth hormone (GH) signaling. It circulates in the blood bound to IGF-binding proteins (IGFBPs) and exerts its effects by binding to the IGF-1 receptor (IGF-1R), which is present on virtually every cell type in the body.[1]
IGF-1’s biological effects include stimulating protein synthesis and muscle hypertrophy, promoting satellite cell activation and proliferation (muscle stem cells), supporting bone formation and mineralization, enhancing neuronal survival and neuroplasticity, and promoting cellular growth and differentiation across multiple tissue types.[2]
What Makes LR3 Different
Natural IGF-1 has a short half-life of approximately 12-15 minutes in circulation because it’s rapidly bound by IGF-binding proteins (IGFBPs) and cleared. IGF-1 LR3 (Long Arg3 IGF-1) has two key modifications: a 13-amino-acid extension at the N-terminus and a substitution of arginine for glutamic acid at position 3.[3]
These modifications dramatically reduce IGF-1 LR3’s affinity for IGFBPs — the binding proteins that normally sequester and inactivate IGF-1 in circulation. The result is that IGF-1 LR3 remains free and bioactive for approximately 20-30 hours, compared to minutes for native IGF-1. This means a much higher proportion of the administered dose reaches target tissues in active form.
Mechanisms Relevant to Recovery and Performance
Muscle Protein Synthesis: IGF-1 activates the PI3K/Akt/mTOR signaling pathway — the master regulator of muscle protein synthesis. This pathway increases the rate at which ribosomes translate mRNA into new muscle proteins, directly supporting muscle growth and repair.[4]
Satellite Cell Activation: Skeletal muscle contains a population of stem cells called satellite cells that lie dormant until activated by damage or growth signals. IGF-1 is one of the primary activators of satellite cells, stimulating them to proliferate and fuse with existing muscle fibers — adding new nuclei and supporting muscle growth and repair.[5]
Anti-Catabolic Effects: IGF-1 signaling through the Akt pathway phosphorylates and inactivates FOXO transcription factors, which are responsible for upregulating muscle breakdown (proteolysis) genes. By suppressing FOXO, IGF-1 reduces muscle protein breakdown — protecting existing muscle mass during recovery and caloric restriction.[4]
Safety Considerations
IGF-1 is a potent growth factor, and potency demands respect. Because it promotes cellular growth broadly, it requires physician oversight to ensure appropriate dosing and monitoring. This is precisely why injectable peptide protocols require a consultation — the therapeutic window must be individualized, and potential interactions with metabolic health (particularly insulin sensitivity) must be considered.
References
- Le Roith D, et al. “The somatomedin hypothesis: 2001.” Endocrine Reviews. 2001;22(1):53-74.
- Laron Z. “Insulin-like growth factor 1 (IGF-1): a growth hormone.” Molecular Pathology. 2001;54(5):311-316.
- Francis GL, et al. “Insulin-like growth factor 1 and 2 in bovine colostrum.” Biochemical Journal. 1988;251(1):95-103.
- Schiaffino S, Mammucari C. “Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway.” Annals of the New York Academy of Sciences. 2011;1228:73-82.
- Charge SB, Rudnicki MA. “Cellular and molecular regulation of muscle regeneration.” Physiological Reviews. 2004;84(1):209-238.
